Quanterix Announces Planned Transition of Chief Financial Officer

Stock Information for Arcadia Biosciences Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Arcadia Biosciences Inc.

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quanterix Announces Appointment of Jason Faessler as Chief Financial Officer
Quanterix Appoints Industry Veteran Geoff Albrecht as Senior Vice President and General Manager of Diagnostics
Quanterix To Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quanterix Releases Financial Results for the First Quarter of 2026
Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimer's Biomarker Testing into Clinical Workflows
Quanterix To Report First Quarter 2026 Financial Results on May 6, 2026

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.